Albert Bourla

Albert Bourla

executive United States

Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.

Born on Oct 21, 1961 (63 years old)

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
189,950
Power
10,721$
Sentiment
7.84
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United States 1 8.00 0.04% +0% 331,002,651 130,883 $21,000,000 8,304$
France 1 7.00 0.09% +0% 65,273,511 57,257 $2,700,000 2,368$
Slovenia 1 8.00 0.09% +0% 2,078,938 1,809 $56,000 49$
Totals 3 398,355,100 189,949 $23,756,000 10,721$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

France France: Albert Bourla is the CEO of Pfizer who commented on Trump's potential Nobel Peace Prize candidacy for his actions during the pandemic. 7

Le Monde: Pfizer : « A la cour de Donald Trump, la flatterie s’inscrit dans le registre du prix Nobel »

United States United States: Pfizer Chief Executive Officer Albert Bourla emphasized the company's commitment to transparency in vaccine data. 8

CNN: Pfizer responds to Trump’s call for Covid-19 vaccine data, says Operation Warp Speed deserves Nobel Peace Prize

Germany Germany: Albert Bourla is the CEO of Pfizer, who received a personalized letter from Trump. 5

Süddeutsche Zeitung: Trump fordert Pharmaunternehmen auf, Preise zu senken - Wirtschaft